Zimbabwe makes historic leap with rapid approval of twice-yearly HIV prevention shot
By Staff Reporter Harare — Zimbabwe has become one of the first African countries to green-light lenacapavir, a revolutionary long-acting HIV prevention drug. The injectable medication was approved in a record 23 days, the Medicines Control Authority of Zimbabwe (MCAZ) announced last Friday. The drug, administered only twice a year as a pre-exposure prophylaxis (PrEP) intervention, […]